Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy

Int J Mol Sci. 2022 Sep 26;23(19):11363. doi: 10.3390/ijms231911363.

Authors

Alessandro Rizzo¹, Angela Dalia Ricci²

Affiliations

¹ Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico "Don Tonino Bello", I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
² Medical Oncology Unit, National Institute of Gastroenterology, "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide [...].

Publication types

Editorial

MeSH terms

Carcinoma, Hepatocellular* / pathology
Carcinoma, Hepatocellular* / therapy
Humans
Immunotherapy
Liver Neoplasms* / pathology
Liver Neoplasms* / therapy

Grants and funding

This research received no external funding.